Connect with us

Sport

Francesco Camarda Set to Join Lecce with Long-Term Deal and Milan Buy-Back Clause

Published

on

Francesco Camarda is set to take the next major step in his young career as he prepares to join Lecce. The highly-rated Italian forward, considered one of the most exciting talents in Italian football, is expected to complete his medical today before officially becoming a Lecce player. This move marks a significant development for both the player and Lecce, as they aim to bolster their attacking options with a promising star of the future.

The agreement will see Camarda sign a long-term contract that runs until 2030, structured as a 1+4 deal. This indicates an initial one-year term, likely with the Primavera or development squad, followed by a four-year professional contract should all go according to plan. Lecce is showing great faith in Camarda’s abilities by offering such a long-term commitment, highlighting their belief in his potential.

While the transfer brings Camarda to Lecce, AC Milan have ensured they remain closely connected to the player’s future. The Rossoneri have inserted a buy-back clause worth €4 million, which can be activated if Lecce chooses to exercise their €3 million option to purchase the young striker. This strategic move keeps Milan in a strong position to bring Camarda back if he develops as expected.

This kind of deal is becoming more common among Italian clubs looking to develop talent in competitive environments while retaining control over their long-term future. For Lecce, acquiring Camarda represents both a short-term reinforcement and a potential long-term gem. For Camarda, it’s a chance to gain regular playing time and grow in a first-team setting.

As Camarda undergoes his medical and finalizes the deal, excitement grows among Lecce fans who are eager to see what the young forward can bring. With his arrival, Lecce continues to show ambition in building a future-oriented squad, while AC Milan keeps a watchful eye on one of their brightest youth products.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

ADVER

Trending